Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors
- PMID: 35935615
- PMCID: PMC9353176
- DOI: 10.3389/fcvm.2022.934946
Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors
Abstract
Background: Routine coronary artery disease (CAD) secondary prevention strategies target standard modifiable cardiovascular risk factors (SMuRFs), which include: diabetes mellitus, dyslipidemia, hypertension, and smoking. However, a significant proportion of patients with acute coronary syndrome (ACS) present without any SMuRFs. The angiographic severity of disease in this population has not yet been investigated.
Methods: After propensity score matching of patients without SMuRFs and patients with ≥1 SMuRFs (ratio 1:3), we used zero-inflated negative binomial regression modeling to investigate the relationship of SMuRF-less status with the angiographic severity of CAD, as measured by the SYNTAX score. Survival analysis was performed to investigate differences in all-cause mortality at 30 days and at the end of follow-up period.
Results: We analyzed 534 patients presenting with ACS who underwent coronary angiography. Of them, 56 (10.5%) presented without any SMuRF. After propensity score matching, the median SYNTAX score was 13.8 (IQR 0-22.1) in 56 SMuRF-less patients and 14 (IQR 5-25) in 166 patients with ≥1 SMuRFs. SMuRF-less status was associated with increased odds of zero SYNTAX score [zero-part model: odds ratio = 2.11, 95% confidence interval (CI): 1.03-4.33], but not with decreased SYNTAX score among patients with non-zero SYNTAX score (count-part model: incidence rate ratio = 0.99, 95% CI: 0.79-1.24); the overall distribution of the SYNTAX score was similar between the two groups (p = 0.26). The 30-day risk for all-cause mortality was higher for SMuRF-less patients compared to patients with ≥1 SMuRFs [hazard ratio (HR) = 3.58, 95% CI: 1.30-9.88]; however, the all-cause mortality risk was not different between the two groups over a median 1.7-year follow-up (HR = 1.72, 95% CI: 0.83-3.57).
Conclusion: Among patients with ACS, the absence of SMuRFs is associated with increased odds for non-obstructive CAD and with increased short-term mortality rates.
Keywords: SYNTAX score; acute coronary syndrome; angiographic severity; myocardial infarction; standard modifiable cardiovascular disease risk factors.
Copyright © 2022 Papazoglou, Farmakis, Zafeiropoulos, Moysidis, Karagiannidis, Stalikas, Kartas, Stamos, Sofidis, Doundoulakis, Giannopoulos, Giannakoulas and Sianos.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors - rationale and design of the "Beyond-SMuRFs Study".BMC Cardiovasc Disord. 2023 Mar 23;23(1):149. doi: 10.1186/s12872-023-03180-4. BMC Cardiovasc Disord. 2023. PMID: 36959584 Free PMC article.
-
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9. Lancet. 2021. PMID: 33711294
-
In-hospital and 1-year outcomes of patients without modifiable risk factors presenting with acute coronary syndrome undergoing PCI: a Sex-stratified analysis.Front Cardiovasc Med. 2023 Dec 20;10:1235667. doi: 10.3389/fcvm.2023.1235667. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38173819 Free PMC article.
-
Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors.Clin Res Cardiol. 2025 Jun;114(6):681-689. doi: 10.1007/s00392-024-02563-7. Epub 2024 Nov 12. Clin Res Cardiol. 2025. PMID: 39531081 Review.
-
No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis.Cardiovasc Interv Ther. 2024 Oct;39(4):403-411. doi: 10.1007/s12928-024-01022-4. Epub 2024 Jun 17. Cardiovasc Interv Ther. 2024. PMID: 38880836 Free PMC article. Review.
Cited by
-
Poor Mental Health Status as a Risk Factor and Prognosticator in SMuRF-Less Acute Myocardial Infarction.J Clin Med. 2025 Apr 11;14(8):2645. doi: 10.3390/jcm14082645. J Clin Med. 2025. PMID: 40283475 Free PMC article.
-
Effect of obstructive sleep apnea on prognosis in patients with acute coronary syndromes with varying numbers of standard modifiable risk factors: insight from the OSA-ACS study.J Thromb Thrombolysis. 2023 Jul;56(1):65-74. doi: 10.1007/s11239-023-02830-w. Epub 2023 May 27. J Thromb Thrombolysis. 2023. PMID: 37243941 Free PMC article.
-
Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors - rationale and design of the "Beyond-SMuRFs Study".BMC Cardiovasc Disord. 2023 Mar 23;23(1):149. doi: 10.1186/s12872-023-03180-4. BMC Cardiovasc Disord. 2023. PMID: 36959584 Free PMC article.
-
Epicardial fat volume evaluated with multidetector computed tomography and other risk factors for prevalence of three-vessel coronary lesions.Eur J Med Res. 2022 Dec 27;27(1):308. doi: 10.1186/s40001-022-00956-w. Eur J Med Res. 2022. PMID: 36572947 Free PMC article.
-
Effect of Cardiovascular Risk Factors on 30-Day All-Cause Mortality in Cardiogenic Shock.J Clin Med. 2023 Jul 24;12(14):4870. doi: 10.3390/jcm12144870. J Clin Med. 2023. PMID: 37510985 Free PMC article.
References
-
- WHO. CVD Atlas: Cardiovascular Diseases. Geneva: WHO; (2021).
-
- Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. (2020) 395:795–808. 10.1016/S0140-6736(19)32008-2 - DOI - PMC - PubMed
-
- Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. (2021) 42:3227–37. 10.1093/eurheartj/ehab484 - DOI - PubMed
-
- Vernon ST, Coffey S, D’Souza M, Chow CK, Kilian J, Hyun K, et al. ST-Segment–Elevation Myocardial Infarction (STEMI) patients without standard modifiable cardiovascular risk factors—how common are they, and what are their outcomes? J Am Heart Assoc. (2019) 8:e013296. 10.1161/JAHA.119.013296 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous